Licensing Fee. In consideration for the licensing rights set forth herein, the Licensee agrees to pay AmericaTowne an initial fee of $35,000, which is due and payable as follows: (i) $5,000 on the Effective Date, and (ii) USD $30,000 on 29 October 2014 (the "Licensing Fee"). The Licensing Fee is non-refundable except as otherwise specifically set forth in this Agreement. At the discretion of AmericaTowne the Licensee may be required to sign a note for any outstanding licensing fee.
Licensing Fee. Licensing fee includes a Granite Shield seal kit, a Granite Shield seal book in PDF, Granite Shield stain removal guide in PDF, Granite Shield worksheet in PDF and Excel spreadsheet, Granite Shield information in PDF, Granite Shield photos and logo in JPG, other Granite Shield related material in PDF and JPG, Granite Shield website. Licensing fee and chemicals are non refundable.
Licensing Fee. In consideration for the License granted hereunder, Licensee shall pay to AnyLogic or an authorized distributor, as applicable, the fee indicated in the applicable invoice or purchase order (the “Licensing Fee”), pursuant to the terms of said invoice or purchase order.
Licensing Fee. In consideration of the rights granted in the License Agreement, LICENSEE issued to LICENSOR a licensing fee payment of 2,500,000 shares of its common stock and such common shares were issued to the LICENSOR as follows: 500,000 shares to the Xxxxxx Trust, 1,000,000 common shares to Xxxxxxx X. Xxxxxx and 1,000,000 common shares to Xxxxxx X. Xxxxxx. In further consideration of the expansion of the license granted to LICENSEE pursuant to Article II of this Amendment, LICENSEE hereby agrees to pay to the LICENSOR an additional licensing fee comprised of 5,924,000 shares of its common stock, to be issued to the LICENSOR as follows: 2,500,000 shares, to the Xxxxxx Trust, 1,424,000 common shares To Xxxxxxx X. Xxxxxx and 2,000,000 common shares to Xxxxxx X. Xxxxxx, with such additional licensing fee shares to be issued on the date LICENSEE executes this Amendment or as soon thereafter as practicable (both licensing fee payments of shares shall be collectively referred to as the "Licensing Fee"). LICENSOR and LICENSEE acknowledge and agree that the LICENSEE'S common stock issued and delivered pursuant to the License Agreement and this Amendment to LICENSOR shall not have any pre-emptive rights of any nature whatsoever and shall be subject to future dilution in the sole and exclusive discretion of LICENSEE for proper corporate purposes.
Licensing Fee. As partial payment for the rights and licenses granted by New River pursuant to this Agreement, Shire shall pay to New River a license fee equal to $48,800,000 within ten (10) Business Days after the Effective Date. This fee shall be non-creditable and non-refundable against any future obligations of Shire under this Agreement, subject to Section 7.3 and Section 13.6.
Licensing Fee. As a new VOMI Academy Partner, Licensee shall pay to VOMI, upon execution of this Agreement, a non-refundable, non-transferable licensing fee of $0.00.
Licensing Fee. LICENSEE shall pay to UNIVERSITY:
(i) On or before thirty (30) calendar days after the EFFECTIVE DATE, a nonrefundable, not creditable (including against royalties or patent costs) initial license fee of [****] Dollars ($[****]);
(ii) On or before the first anniversary of the EFFECTIVE DATE, a nonrefundable, not creditable (including against royalties or patent costs) second license fee of [****] Dollars ($[****]);
(iii) On or before the second anniversary of the EFFECTIVE DATE, a nonrefundable, not creditable (including against royalties or patent costs) third license fee of [****]Dollars ($[****]); and CONFIDENTIAL TREATMENT REQUESTED UNDER C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 230.406. [****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.
(iv) Within thirty (30) calendar days after the FIRST COMMERCIAL SALE of the first of either a LICENSED PRODUCT and/or a first service utilizing a LICENSED PROCESS in a cancer field other than multiple myeloma (e.g. breast cancer, kidney cancer, lung cancer, and all other cancers included in the LICENSED FIELD), LICENSEE shall pay to UNIVERSITY a non-refundable and not creditable (including against royalties or patent costs), additional licensing fee of [****] Dollars ($[****]) for such additional cancer field. For the avoidance of doubt, the payment under this Article 5.1(a) (iv) shall only be paid with respect to the first such additional cancer field for which the Company makes a FIRST COMMERCIAL SALE.
Licensing Fee. Licensee will pay University the Licensing Fee, payable as set forth in Schedule B Section V. Licensing Fee payment(s) shall be non-refundable and are not advances on Royalties; Licensee will not deduct any amounts paid pursuant to this subsection from Royalties.
Licensing Fee. In addition to the Advance payable to TufAmerica, DMG will pay TufAmerica a non-recoupable licensing fee (“Licensing Fee”) up to [*] Dollars ($[*]). The Licensing Fee is payable as set forth in Section 4.2
